无创产前筛查提示母体恶性肿瘤时的影像学作用
本文阐述无创产前筛查(NIPS)可因母体肿瘤来源的游离DNA而提示隐匿性恶性肿瘤,最常见的NIPS异常为多倍体或常染色体单体。影像学在排查中起关键作用:超声适用于有定位症状或可触及肿块时;无定位症状时推荐全身MRI作为无辐射的首选检查;CT因辐射剂量较高仅限特殊情形。
要点
- NIPS提示多倍体或常染色体单体时需警惕隐匿性母体恶性肿瘤。
- 有定位症状或可触及肿块时,超声是无辐射的合理初始影像检查。
- 无定位症状或临床可触及发现时,推荐全身MRI作为无辐射首选排查手段。
核心结论
- NIPS可检测到母体肿瘤来源的游离DNA,表现为多倍体或常染色体单体等基因组异常,提示隐匿性母体恶性肿瘤。
- 影像学在排查NIPS提示的隐匿性恶性肿瘤中起关键作用。
研究设计与样本
- 本文为综述/经验文章,旨在提高对妊娠期NIPS提示隐匿性恶性肿瘤这一罕见临床场景的认识并指导影像学评估。
诊断标准与关键数值
- NIPS最常见的提示隐匿性母体恶性肿瘤的异常为多倍体或常染色体单体。
- NIPS最常检测到的恶性肿瘤为白血病、淋巴瘤、乳腺癌和结肠癌。
临床应用与阅片要点
- 妊娠期有定位症状或可触及肿块时,超声是无辐射的合理影像检查方式。
- 无定位症状或临床可触及发现时,推荐全身MRI作为无辐射的首选检查以排查隐匿性恶性肿瘤。
- 可根据临床症状、实践模式和可用资源,初始或作为MRI随访进行乳腺超声、胸部X线及针对性超声评估。
- CT因辐射剂量较高,仅限特殊情形使用。
局限性
- 原文指出目前尚无关于此类患者影像学评估的共识指南。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Noninvasive prenatal screening (NIPS) tests for fetal chromosomal anomalies through maternal blood sampling. It is becoming widely available and standard of care for pregnant women in many countries. It is performed in the first trimester of pregnancy, usually between 9 and 12 weeks. Fragments of fetal cell-free deoxyribonucleic acid (DNA) floating in maternal plasma are detected and analyzed by this test to assess for chromosomal aberrations. Similarly, maternal tumor-derived cell-free DNA (ctDNA) released from the tumor cells also circulates in the plasma. Hence, the presence of genomic anomalies originating from maternal tumor-derived DNA may be detected on the NIPS-based fetal risk assessment in pregnant patients. Presence of multiple aneuploidies or autosomal monosomies are the most commonly reported NIPS abnormalities detected with occult maternal malignancies. When such results are received, the search for an occult maternal malignancy begins, in which imaging plays a crucial role. The most commonly detected malignancies via NIPS are leukemia, lymphoma, breast and colon cancers. Ultrasound is a reasonable radiation-free modality for imaging during pregnancy, specially when there are localizing symptoms or findings, such as palpable lumps. While there are no consensus guidelines on the imaging evaluation for these patients, when there are no localizing symptoms or clinically palpable findings, whole body MRI is recommended as the radiation-free modality of choice to search for an occult malignancy. Based on clinical symptoms, practice patterns, and available resources, breast ultrasound, chest radiographs, and targeted ultrasound evaluations can also be performed initially or as a follow-up for MRI findings. CT is reserved for exceptional circumstances due to its higher radiation dose. This article intends to increase awareness of this rare but stressful clinical scenario and guide imaging evaluation for occult malignancy detected via NIPS during pregnancy.
引用
- Jha, Lenaerts, Vermeesch, et al. Noninvasive prenatal screening and maternal malignancy: role of imaging. Abdom Radiol (NY). 2023. PMID: 37095202. doi:10.1007/s00261-023-03913-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。